Geospace Technologies

Ligand Pharmaceuticals Inc. (NASDAQ: LGND) reported on Tuesday it expects its fiscal 2015 earnings per share to be in a range of $2.14 to $2.18, falling short of the consensus estimate of $2.42. The company expects fiscal 2015 sales to be $81 million to $83 million, also below the consensus...

Lemelson Capital Management announced on Monday it has acquired a 2 percent stake in Geospace Technologies Corp (NASDAQ: GEOS). Lemelson Capital Management made headlines recently when BarclayHedge, a global leader in fund performance ranking assessment, ranked Lemelson Capital's Amvona...